• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光相干断层扫描在阿柏西普治疗息肉状脉络膜血管病变中对息肉样病变闭合的特征。

OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.

机构信息

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.

Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and.

出版信息

Retina. 2022 Jan 1;42(1):114-122. doi: 10.1097/IAE.0000000000003285.

DOI:10.1097/IAE.0000000000003285
PMID:34412103
Abstract

PURPOSE

To evaluate whether optical coherence tomography (OCT) can determine polypoidal lesion (PL) perfusion in polypoidal choroidal vasculopathy eyes after 12 months of aflibercept monotherapy. Polypoidal lesion perfusion status, assessed by indocyanine green angiography, is an important anatomical outcome in polypoidal choroidal vasculopathy management.

METHODS

Post hoc data from a prospective randomized, open-label, study in eyes with polypoidal choroidal vasculopathy undergoing monotherapy with aflibercept evaluated PL perfusion status based on indocyanine green angiography (gold standard) and OCT features from baseline to 12 months.

RESULTS

Individual PLs (110 in total) from 48 eyes (48 patients) showed at 12 months; 57/110 PLs (51.8%) were closed on indocyanine green angiography. At 12 months, eyes with closed PLs were more likely to have the following OCT features: 1) no subretinal fluid (67.1% vs. 32.9%), 2) smaller pigment epithelial detachment height (67.2 [±43.8] vs. 189.2 [±104.9] μm), 3) densely hyperreflective pigment epithelial detachment contents (84.0% vs. 16.0%), 4) an absence of a hyperreflective ring(64.0% vs. 36.0%), and a 5) indistinct overlying retinal pigment epithelial (71.4% vs. 28.6%) (all P < 0.05). The three highest performing OCT features that differentiated perfused from closed PLs were (1), (3), and (4) (area under the receiver operating characteristic curve 0.85, 0.73, and 0.70, respectively). A combination of these three features achieved an area under the receiver operating characteristic curve of 0.90.

CONCLUSION

Polypoidal lesion closure, an important anatomical treatment outcome in polypoidal choroidal vasculopathy typically defined by indocyanine green angiography, can be accurately detected by specific OCT features.

摘要

目的

评估光学相干断层扫描(OCT)能否在接受阿柏西普单药治疗 12 个月后确定息肉样脉络膜血管病变(PCV)眼中的息肉样病变(PL)灌注情况。通过吲哚菁绿血管造影评估的 PL 灌注状态是 PCV 管理中的一个重要解剖学结果。

方法

对接受阿柏西普单药治疗的 PCV 患者进行的前瞻性随机、开放标签、研究的事后数据分析,根据吲哚菁绿血管造影(金标准)和基线至 12 个月的 OCT 特征评估 PL 灌注情况。

结果

48 只眼(48 例患者)的 110 个单独 PL 在 12 个月时显示;110 个 PL 中有 57 个(51.8%)在吲哚菁绿血管造影上闭合。在 12 个月时,PL 闭合的眼睛更可能具有以下 OCT 特征:1)无视网膜下积液(67.1%对 32.9%),2)较小的色素上皮脱离高度(67.2[±43.8]μm 对 189.2[±104.9]μm),3)浓密高反射性色素上皮脱离内容物(84.0%对 16.0%),4)无高反射性环(64.0%对 36.0%),5)覆盖的视网膜色素上皮不明显(71.4%对 28.6%)(均 P<0.05)。区分灌注与未灌注 PL 的三个性能最高的 OCT 特征分别为(1)、(3)和(4)(受试者工作特征曲线下面积分别为 0.85、0.73 和 0.70)。这三个特征的组合获得了 0.90 的受试者工作特征曲线下面积。

结论

PCV 中典型的重要解剖学治疗结果息肉样病变(PL)闭合,通常通过吲哚菁绿血管造影定义,可通过特定的 OCT 特征准确检测到。

相似文献

1
OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.光相干断层扫描在阿柏西普治疗息肉状脉络膜血管病变中对息肉样病变闭合的特征。
Retina. 2022 Jan 1;42(1):114-122. doi: 10.1097/IAE.0000000000003285.
2
Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.玻璃体内阿柏西普治疗后息肉样脉络膜血管病变完全息肉样消退的时间。
Ophthalmol Retina. 2022 Jan;6(1):21-28. doi: 10.1016/j.oret.2021.03.012. Epub 2021 Mar 27.
3
Aflibercept Treatment in Polypoidal Choroidal Vasculopathy: Results of a Prospective Study in a Caucasian Population.阿柏西普治疗息肉样脉络膜血管病变:一项针对高加索人群的前瞻性研究结果
Ophthalmologica. 2018;240(4):208-212. doi: 10.1159/000488808. Epub 2018 May 25.
4
Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.光动力疗法联合玻璃体内注射阿柏西普(阿瓦斯汀)治疗后,视盘黑素细胞瘤合并息肉状脉络膜血管病变:一例报告
BMC Ophthalmol. 2018 Oct 12;18(1):267. doi: 10.1186/s12886-018-0927-7.
5
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.阿柏西普治疗性延长方案用于息肉状脉络膜血管病变的两年结果
Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1891-1897. doi: 10.1007/s00417-017-3718-6. Epub 2017 Jul 1.
6
One-year outcome of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.玻璃体内注射阿柏西普与维替泊芬光动力疗法联合治疗息肉状脉络膜血管病变的一年疗效
Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):541-548. doi: 10.1007/s00417-016-3500-1. Epub 2016 Sep 30.
7
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS OF CLASSIC CHOROIDAL NEOVASCULARIZATION IN POLYPOIDAL CHOROIDAL VASCULOPATHY.光学相干断层扫描血管造影在息肉状脉络膜血管病变中的典型脉络膜新生血管的表现。
Retina. 2022 Jan 1;42(1):123-128. doi: 10.1097/IAE.0000000000003264.
8
REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.光动力疗法联合阿柏西普治疗息肉状脉络膜血管病变后脉络膜血管密度降低。
Retina. 2021 Jan 1;41(1):156-161. doi: 10.1097/IAE.0000000000002793.
9
Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy.息肉样脉络膜血管病变的初始治疗:雷珠单抗联合光动力疗法或固定剂量阿柏西普单药治疗。
Eur J Ophthalmol. 2020 Nov;30(6):1473-1479. doi: 10.1177/1120672119871886. Epub 2019 Sep 2.
10
INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH MORNING GLORY SYNDROME.玻璃体内注射阿柏西普治疗与牵牛星综合征相关的息肉状脉络膜血管病变。
Retin Cases Brief Rep. 2020 Summer;14(3):278-281. doi: 10.1097/ICB.0000000000000698.

引用本文的文献

1
Macular neovascularization and polypoidal choroidal vasculopathy: phenotypic variations, pathogenic mechanisms and implications in management.黄斑新生血管和息肉样脉络膜血管病变:表型变异、发病机制及其在治疗中的意义。
Eye (Lond). 2024 Mar;38(4):659-667. doi: 10.1038/s41433-023-02764-w. Epub 2023 Oct 6.
2
Advances in multi-modal non-invasive imaging techniques in the diagnosis and treatment of polypoidal choroidal vasculopathy.多模态无创成像技术在息肉样脉络膜血管病变诊断与治疗中的进展
Front Med (Lausanne). 2023 Jul 27;10:1221846. doi: 10.3389/fmed.2023.1221846. eCollection 2023.
3
Joint Multimodal Deep Learning-based Automatic Segmentation of Indocyanine Green Angiography and OCT Images for Assessment of Polypoidal Choroidal Vasculopathy Biomarkers.
基于联合多模态深度学习的吲哚菁绿血管造影和光学相干断层扫描图像自动分割,用于评估息肉状脉络膜血管病变生物标志物
Ophthalmol Sci. 2023 Feb 24;3(3):100292. doi: 10.1016/j.xops.2023.100292. eCollection 2023 Sep.
4
Polypoidal Choroidal Vasculopathy: An Update on Diagnosis and Treatment.息肉样脉络膜血管病变:诊断与治疗的最新进展
Clin Ophthalmol. 2023 Jan 5;17:53-70. doi: 10.2147/OPTH.S385827. eCollection 2023.